Metadoxine

DB16554InvestigationalSmall molecule

Metadoxine is a medication used to increase the clearance of alcohol in patients with chronic alcohol dependancy.

Chemical structure of Metadoxine
Formula / weight
C13H18N2O6 · 298.295 g/mol (avg)
Also known as
Pyridoxine mixture with Pyrrolidonecarboxylic Acid · Pyridoxine pyroglutamate
Code names
277-913-8

Resolves to

Compound
UNIIEJQ7M98H5JCAS74536-44-0
Clinical / RWD
ATCA05BA09
Structure
InChIKeyRYKKQQUKJJGFMN-HVDRVSQOSA-NSMILESOC(=O)[C@@H]1CCC(=O)N1.CC1=NC=C(CO)C(CO)=C1O
Targets
P30531SLC6A1

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
10Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
2ContraindicationsEach with its own population and attribute set
Sign in
4Marketed productsAcross 2 countries and 2 labellers
Sign in
1ATC codeIncluding every combination product, plus 19 drug categories
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Metadoxine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In